Company news
Hyperfine, Inc. (NASDAQ:HYPR) news
Every Hyperfine, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
August 26, 2026
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of ...
August 20, 2026
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growin...
July 30, 2026
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
June 22, 2026
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
May 26, 2026
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency ...
May 22, 2026
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
May 12, 2026
Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference
May 6, 2026
Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution
April 29, 2026
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026
April 28, 2026
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software
April 9, 2026
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine
March 23, 2026
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 5, 2026
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities
January 27, 2026
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics
January 20, 2026
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
January 15, 2026
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
January 12, 2026
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
January 9, 2026
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable M...
January 6, 2026
Hyperfine Announces Regulatory Approval of the Swoop® System in India
December 17, 2025
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancin...
December 15, 2025
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
November 20, 2025
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
November 19, 2025
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
November 13, 2025
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025
October 30, 2025
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
October 21, 2025
Hyperfine Announces Pricing of $17.5 Million Public Offering
October 16, 2025
Hyperfine Announces Proposed Public Offering
October 15, 2025
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the N...
October 15, 2025
Hyperfine Swoop® System Referenced in France’s Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MR...
October 13, 2025
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
October 6, 2025
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Sof...
September 2, 2025
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
August 25, 2025
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
August 13, 2025
Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop...
August 4, 2025
Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departm...
July 31, 2025
Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025
July 30, 2025
Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzh...
July 28, 2025
Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care
July 24, 2025
Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® ...
July 23, 2025
Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software
July 17, 2025
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
June 11, 2025
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap...
June 2, 2025
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® ...
May 28, 2025
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
May 15, 2025
Hyperfine, Inc. Reports First Quarter 2025 Financial Results
May 13, 2025
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025
April 29, 2025
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
April 15, 2025